Our sister publication, Pharmacy Times, covered recent study results that could lead to an FDA approval for MDMA to treat post-traumatic stress disorder by the end of 2023.
Ashley Gallagher
Advertisement
Articles by Ashley Gallagher
Advertisement
Latest Updated Articles
- MDMA-Assisted Therapy Demonstrates Significant Reductions in Post-Traumatic Stress Disorder Symptoms in Phase 3 Study
Published: September 28th 2023 | Updated:
Advertisement
Advertisement
Trending on Cannabis Science and Technology - Cannabis Industry News, Insights
1
Clinical Trial Finds Cannabis Oil May Help with Symptoms of Systemic Sclerosis
2
Cannabis Cultivator Operations: Interview with Zacariah Hildenbrand and Adam Jacques
3
Nurse-Led Education on Medical Cannabis May Support Fibromyalgia Patients, Study Finds
4
Virginia Cannabis Control Authority Forms New Practitioner Training Program
5
